InvestorsHub Logo
Followers 80
Posts 24702
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 05/12/2022 7:39:03 AM

Thursday, May 12, 2022 7:39:03 AM

Post# of 27621
MITO - .1901 Pre-market .35/.3501

Stealth BioTherapeutics Reports Received Orphan Drug Designation For Elamipretide For Treatment Of Duchenne Muscular Dystrophy; BZ NOTE: A Listing On The FDA's AccessData.gov Wednesday Showed This Information

https://stockcharts.com/h-sc/ui?s=mito
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.